doi: 10.1016/S0140-6736(10)60590-9 [DOI] [PubMed] [Google Scholar] 41
GLP-1 RAs use was significantly associated with a lower risk of HHF in patients with a history of HF (HR 0.65
Deletion of SRF has been discovered to contribute to several processes involving in epileptogenesis, such as neuroinflammation, mossy fiber sprouting, and cell death [113, 114]
Immunogenicity Testing As a modified peptide with non-natural amino acid substitutions and fatty acid modifications, semaglutide has potential immunogenic risk
Tirzepatide can cause rapid fat mobilization, and the lipotropic agents in Lipo C, like choline and methionine, are thought to help the liver process this increased fatty acid load more efficiently, potentially reducing hepatic stress